Literature DB >> 26432017

Intercellular Transfer of Cancer Drug Resistance Traits by Extracellular Vesicles.

Diana Sousa1, Raquel T Lima2, M Helena Vasconcelos3.   

Abstract

Extracellular vesicles (EVs) are nanosized particles (100-1000 nm) enclosed by a phospholipid bilayer that have been described as important mediators of intercellular communication. The role of EVs in oncobiology has been extensively studied, including their contribution to the horizontal transfer of drug resistance from drug-resistant to drug-sensitive cancer cells. This review focuses on the EVs cargo responsible for this intercellular transfer of drug resistance; namely, drug-efflux pumps, miRNAs, long noncoding RNAs (lncRNAs), and other mediators. Additionally, the known molecular mechanisms and features of this transfer are discussed. This is an emerging area of research and we highlight topics that need to be further studied to fully understand and counteract the intercellular transfer of drug resistance mediated by EVs.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26432017     DOI: 10.1016/j.molmed.2015.08.002

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  57 in total

Review 1.  A historical and evolutionary perspective on the biological significance of circulating DNA and extracellular vesicles.

Authors:  Janine Aucamp; Abel J Bronkhorst; Christoffel P S Badenhorst; Piet J Pretorius
Journal:  Cell Mol Life Sci       Date:  2016-09-20       Impact factor: 9.261

2.  Is there horizontal transfer of the oncogene BCR-ABL mediated by extracellular vesicles released by chronic myeloid leukemia cells?: PS203.

Authors:  A Teixeira; D Sousa; C P R Xavier; M H Vasconcelos
Journal:  Porto Biomed J       Date:  2017-09-01

3.  Is P-glycoprotein relevant for the release of microvesicles by tumor cells?: PS212.

Authors:  I Castro; C P R Xavier; M H Vasconcelos
Journal:  Porto Biomed J       Date:  2017-09-01

Review 4.  Mechanisms of tumor cell resistance to the current targeted-therapy agents.

Authors:  Gholamreza Khamisipour; Farhad Jadidi-Niaragh; Abdolreza Sotoodeh Jahromi; Keivan Zandi; Mohammad Hojjat-Farsangi
Journal:  Tumour Biol       Date:  2016-05-07

5.  Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs.

Authors:  Mahendran Chinnappan; Akhil Srivastava; Narsireddy Amreddy; Mohammad Razaq; Vipul Pareek; Rebaz Ahmed; Meghna Mehta; Jo Elle Peterson; Anupama Munshi; Rajagopal Ramesh
Journal:  Cancer Lett       Date:  2020-05-19       Impact factor: 8.679

Review 6.  Exosomes as Theranostic Targets: Implications for the Clinical Prognosis of Aggressive Cancers.

Authors:  Richa Gulati; Dhruva Nandi; Koustav Sarkar; P Venkataraman; K M Ramkumar; Priya Ranjan; Rajiv Janardhanan
Journal:  Front Mol Biosci       Date:  2022-06-23

Review 7.  Exosomes: novel implications in diagnosis and treatment of gastrointestinal cancer.

Authors:  Mohammad Rahbari; Nuh Rahbari; Christoph Reissfelder; Juergen Weitz; Christoph Kahlert
Journal:  Langenbecks Arch Surg       Date:  2016-06-24       Impact factor: 3.445

8.  Exosome-derived miR-210 involved in resistance to osimertinib and epithelial-mesenchymal transition in EGFR mutant non-small cell lung cancer cells.

Authors:  Kakeru Hisakane; Masahiro Seike; Teppei Sugano; Akiko Yoshikawa; Kuniko Matsuda; Natsuki Takano; Satoshi Takahashi; Rintaro Noro; Akihiko Gemma
Journal:  Thorac Cancer       Date:  2021-05-03       Impact factor: 3.500

9.  Inhibition of Exosome Release Sensitizes U937 Cells to PEGylated Liposomal Doxorubicin.

Authors:  Shirin Hekmatirad; Milad Moloudizargari; Ali Akbar Moghadamnia; Sohrab Kazemi; Mousa Mohammadnia-Afrouzi; Maryam Baeeri; Fatemeh Moradkhani; Mohammad Hossein Asghari
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

10.  Oncogene-regulated release of extracellular vesicles.

Authors:  Seda Kilinc; Rebekka Paisner; Roman Camarda; Suprit Gupta; Olga Momcilovic; Rebecca A Kohnz; Baris Avsaroglu; Noelle D L'Etoile; Rushika M Perera; Daniel K Nomura; Andrei Goga
Journal:  Dev Cell       Date:  2021-06-11       Impact factor: 13.417

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.